• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  DMD: HOPE-2 Trial Testing CAP-1002 Cleared to Continue by Board

  Posted by MD forums Moderator on August 19, 2019 at 11:41 am

  

  The HOPE-2 trial has been cleared by an independent review board to resume testing CAP-1002 therapy on boys and young men with Duchenne muscular dystrophy. Read more about it here.

  What do you think of this news?

  MD forums Moderator replied 5 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply